GlassScriptPhysician profile
Byron K Ellis
NPI 1821046780
$117,736.72
in general payments reported to CMS, 2019-2025
55 companies · $4,709 in 2025
The $4,709 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $7,045 · 2021: $9,872 · 2022: $24K · 2023: $21K · 2024: $19K · 2025: $4,709.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $8,913 · Travel and Lodging: $5,623 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,905.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,100.00 |
| Food and Beverage | $8,913.34 |
| Travel and Lodging | $5,622.51 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $82,032.29 | 2019-2024 | Xarelto |
| Shockwave Medical, INC | $12,947.07 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $8,036.10 | 2019-2025 | Xience Skypoint, Supera, Acculink |
| Medtronic Vascular, INC. | $2,171.69 | 2019-2020 | |
| Boston Scientific Corporation | $2,052.25 | 2019-2025 | Watchman Access System, Bodyguardian, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $1,322.22 | 2019-2025 | |
| Amgen INC. | $891.67 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $802.98 | 2019-2025 | Farxiga, Wainua |
| E.R. Squibb & Sons, L.L.C. | $711.26 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $622.92 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $606.72 | 2022-2023 | Optimizer |
| Merck Sharp & Dohme LLC | $566.81 | 2021-2025 | Verquvo, Winrevair, Capvaxive |
| Abiomed | $547.94 | 2024 | Impella |
| Medtronic, INC. | $417.24 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Harmony |
| Cvrx, INC. | $400.75 | 2022-2024 | Barostim Neo System |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $397.94 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $313.91 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $300.56 | 2019-2023 | |
| Heartflow, INC. | $205.47 | 2019-2025 | Ffrct |
| Amarin Pharma, INC. | $200.26 | 2019-2022 | |
| Lexicon Pharmaceuticals, INC. | $190.77 | 2023-2024 | Inpefa |
| Biotronik INC. | $187.03 | 2019-2022 | |
| Cardiva Medical, INC. | $176.69 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Optowire |
| Penumbra, INC. | $171.11 | 2025 | Indigo System |
| Novo Nordisk INC | $168.01 | 2021-2025 | |
| Astellas Pharma US INC | $134.63 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $131.38 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $112.30 | 2019-2025 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $95.52 | 2019-2024 | Praluent, Evkeeza |
| Esperion Therapeutics, INC. | $93.04 | 2021-2024 | Nexletol |
| Azurity Pharmaceuticals, INC. | $84.15 | 2024 | Edarbi |
| Cook Medical LLC | $79.43 | 2019-2024 | Zilver Ptx |
| Bayer Healthcare Pharmaceuticals INC. | $61.06 | 2021-2025 | |
| Philips North America LLC | $40.43 | 2023 | |
| Avvisto Therapeutics, LLC | $37.99 | 2025 | Cycloset |
| Altathera Pharmaceuticals LLC | $35.66 | 2023-2024 | Sotalol Hydrochloride |
| Kiniksa Pharmaceuticals, LTD. | $34.55 | 2023 | Arcalyst |
| Irhythm Technologies, INC. | $31.03 | 2022 | |
| Bolton Medical INC | $29.65 | 2020 | |
| Althera Pharmaceuticals LLC | $29.35 | 2022 | |
| Zoll Circulation INC | $27.00 | 2022 | |
| Edwards Lifesciences Corporation | $25.73 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kowa Pharmaceuticals America, INC. | $25.41 | 2021-2022 | |
| Inari Medical, INC. | $23.94 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Alnylam Pharmaceuticals INC. | $23.40 | 2023 | Onpattro |
| Inspiremd LTD | $23.26 | 2025 | Cguard Prime Carotid Stent System |
| Bardy Diagnostics, INC. | $22.63 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $16.63 | 2020 | |
| Agepha Pharma Fz LLC | $16.42 | 2024 | Lodoco |
| Chiesi USA, INC. | $15.97 | 2025 | Kengreal |
| Cardiovascular Systems INC. | $15.30 | 2019 | |
| Teleflex LLC | $15.07 | 2023 | Trapliner |
| Becton, Dickinson and Company | $14.13 | 2024 | Rotarexs 6 F X 135 Cm |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Byron Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.